LMR Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-59
| Closed | -$13.5K | – | 1420 |
|
|
2025
Q4 | $13.5K | Buy |
59
+57
| +2,850% | +$13K | ﹤0.01% | 1427 |
|
|
2025
Q3 | $463 | Sell |
2
-6,099
| -100% | -$1.24M | ﹤0.01% | 1422 |
|
|
2025
Q2 | $1.13M | Sell |
6,101
-3,217
| -35% | -$598K | 0.01% | 764 |
|
|
2025
Q1 | $1.95M | Buy |
+9,318
| New | +$1.81M | 0.02% | 668 |
|
|
2023
Q3 | – | Sell |
-20,007
| Closed | -$2.7M | – | 927 |
|
|
2023
Q2 | $2.7M | Buy |
+20,007
| New | +$2.93M | 0.03% | 313 |
|
|
2022
Q4 | – | Sell |
-3,283
| Closed | -$441K | – | 1090 |
|
|
2022
Q3 | $441K | Sell |
3,283
-21,668
| -87% | -$3.11M | 0.01% | 905 |
|
|
2022
Q2 | $3.82M | Buy |
+24,951
| New | +$3.81M | 0.06% | 338 |
|
|
2021
Q4 | – | Sell |
-22,097
| Closed | -$2.38M | – | 1135 |
|
|
2021
Q3 | $2.38M | Buy |
22,097
+11,200
| +103% | +$1.28M | 0.03% | 419 |
|
|
2021
Q2 | $1.23M | Sell |
10,897
-8,447
| -44% | -$951K | 0.02% | 475 |
|
|
2021
Q1 | $2.09M | Buy |
19,344
+10,981
| +131% | +$1.17M | 0.05% | 319 |
|
|
2020
Q4 | $896K | Sell |
8,363
-16,049
| -66% | -$1.54M | 0.01% | 296 |
|
|
2020
Q3 | $2.14M | Buy |
+24,412
| New | +$2.3M | 0.04% | 151 |
|
|
2020
Q2 | – | Sell |
-17,254
| Closed | -$1.3M | – | 586 |
|
|
2020
Q1 | $1.3M | Buy |
17,254
+997
| +6% | +$84.9K | 0.06% | 117 |
|
|
2019
Q4 | $1.44K | Buy |
+16,257
| New | +$1.35M | ﹤0.01% | 167 |
|
|
2018
Q3 | – | Sell |
-4,417
| Closed | -$409K | – | 344 |
|
|
2018
Q2 | $409K | Sell |
4,417
-30,607
| -87% | -$2.99M | 0.02% | 299 |
|
|
2018
Q1 | $3.39M | Hold |
35,024
| – | – | 0.35% | 47 |
|
|
2017
Q4 | $3.39M | Buy |
+35,024
| New | +$3.3M | 0.35% | 47 |
|
|
2017
Q3 | – | Sell |
-42,559
| Closed | -$3.09M | – | 310 |
|
|
2017
Q2 | $3.09M | Buy |
42,559
+1,566
| +4% | +$105K | 0.19% | 102 |
|
|
2017
Q1 | $2.67M | Buy |
40,993
+37,515
| +1,079% | +$2.36M | 0.26% | 70 |
|
|
2016
Q4 | $217K | Sell |
3,478
-1,165
| -25% | -$71.1K | 0.03% | 308 |
|
|
2016
Q3 | $292K | Sell |
4,643
-11,342
| -71% | -$734K | 0.03% | 309 |
|
|
2016
Q2 | $990K | Buy |
15,985
+7,364
| +85% | +$449K | 0.15% | 194 |
|
|
2016
Q1 | $492 | Buy |
+8,621
| New | +$481K | 0.05% | 275 |
|
|
2015
Q4 | – | Sell |
-173,957
| Closed | -$9.46M | – | 219 |
|
|
2015
Q3 | $9.46M | Buy |
173,957
+154,948
| +815% | +$10.1M | 1.03% | 22 |
|
|
2015
Q2 | $1.28M | Buy |
19,009
+544
| +3% | +$35.5K | 0.16% | 191 |
|
|
2015
Q1 | $1.08M | Sell |
18,465
-10,854
| -37% | -$656K | 0.15% | 180 |
|
|
2014
Q4 | $1.92M | Buy |
29,319
+15,782
| +117% | +$995K | 0.25% | 95 |
|
|
2014
Q3 | $782K | Buy |
+13,537
| New | +$752K | 0.06% | 151 |
|
Other funds holding ABBV
VCM
VPM
LMR Partners's ABBV Position: Q1 2026 in Review
LMR Partners sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 59 shares — an estimated $13.5K sold.
LMR Partners first reported a position in ABBV in Q3 2014 and held it in 28 quarters. The position peaked at $9.46M in Q3 2015. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- LMR Partners reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
- LMR Partners sold 59 AbbVie shares in Q1 2026, an estimated $13.5K.
- LMR Partners first reported a position in AbbVie in Q3 2014 and held it in 28 quarters.
- LMR Partners's AbbVie position peaked at $9.46M in Q3 2015.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.